Crunch Time Approaches For Roche Over EU Pharmacovigilance Failures
This article was originally published in SRA
Executive Summary
The European Medicines Agency has concluded its second round of investigations into the failure by Roche to comply with its pharmacovigilance obligations in relation to 19 centrally authorized drugs1.